HK1254028A1 - 抗瘧疾組合物和方法 - Google Patents

抗瘧疾組合物和方法

Info

Publication number
HK1254028A1
HK1254028A1 HK18112876.4A HK18112876A HK1254028A1 HK 1254028 A1 HK1254028 A1 HK 1254028A1 HK 18112876 A HK18112876 A HK 18112876A HK 1254028 A1 HK1254028 A1 HK 1254028A1
Authority
HK
Hong Kong
Prior art keywords
methods
malaria
compositions
malaria compositions
Prior art date
Application number
HK18112876.4A
Other languages
English (en)
Inventor
詹姆斯．戈勒姆．博伊德
托馬斯‧J‧鮑威爾
Original Assignee
人工細胞科技公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 人工細胞科技公司 filed Critical 人工細胞科技公司
Publication of HK1254028A1 publication Critical patent/HK1254028A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
HK18112876.4A 2015-09-16 2018-10-10 抗瘧疾組合物和方法 HK1254028A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562219260P 2015-09-16 2015-09-16

Publications (1)

Publication Number Publication Date
HK1254028A1 true HK1254028A1 (zh) 2019-07-12

Family

ID=58289798

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112876.4A HK1254028A1 (zh) 2015-09-16 2018-10-10 抗瘧疾組合物和方法

Country Status (10)

Country Link
US (2) US9968665B2 (zh)
EP (1) EP3349788A4 (zh)
JP (1) JP6934862B2 (zh)
CN (1) CN108025052B (zh)
AU (1) AU2016322544B2 (zh)
CA (1) CA2998540C (zh)
HK (1) HK1254028A1 (zh)
IL (1) IL257895B2 (zh)
MX (1) MX2018003103A (zh)
WO (1) WO2017048689A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US9968665B2 (en) 2015-09-16 2018-05-15 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
EP3658126B1 (en) 2017-07-26 2021-09-08 Albert-Ludwigs-Universität Freiburg Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells
AU2019355843A1 (en) * 2018-10-04 2021-03-04 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
CN113035298B (zh) * 2021-04-02 2023-06-20 南京信息工程大学 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676340B2 (en) 1993-05-25 1997-03-06 Wyeth Holdings Corporation Adjuvants for vaccines against respiratory syncytial virus
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
CA2494193A1 (en) 2002-08-12 2004-02-19 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes
JP2007500210A (ja) 2003-04-10 2007-01-11 スリーエム イノベイティブ プロパティズ カンパニー 金属含有微粒子担体材料を使用した免疫反応調節物質化合物の送達
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
GB0420634D0 (en) * 2004-09-16 2004-10-20 Glaxosmithkline Biolog Sa Vaccines
DK1850832T3 (en) 2005-02-07 2015-04-13 Lipotek Pty Ltd adjuvanting
DE102005044400A1 (de) 2005-09-16 2007-03-22 Capsulution Nanoscience Ag Verfahren zur Verkapselung und kontrollierten Freisetzung von schwer wasserlöslichen (hydrophoben) flüssigen und festen Wirkstoffen
WO2007050569A2 (en) 2005-10-25 2007-05-03 Donald Templeton Haynie Polypeptide multilayer films and methods
EP3085373A1 (en) 2006-02-22 2016-10-26 3M Innovative Properties Company Immune response modifier conjugates
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
US7723294B2 (en) 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP2002847A1 (en) 2007-06-12 2008-12-17 Capsulution Nanoscience AG Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
WO2009082440A2 (en) * 2007-12-18 2009-07-02 Vaxinnate Corporation Compositions of toll-like receptor agonists and malaria antigens and methods of use
US7846824B2 (en) 2008-03-18 2010-12-07 Applied Materials, Inc. Methods for forming a titanium nitride layer
EP2346523A4 (en) * 2008-10-01 2014-12-31 Us Health MULTICOMPONENT VACCINE AGAINST MALARIA INDUCING SUSTAINABLE IMMUNE RESPONSES AGAINST PLASMODIUM
WO2010115229A1 (en) 2009-04-09 2010-10-14 The University Of Melbourne Immunogenic composition and uses thereof
WO2011022002A1 (en) * 2009-08-18 2011-02-24 The Rockefeller University Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
AU2011276251B2 (en) 2010-07-07 2015-02-05 Artifical Cell Technologies, Inc. Respiratory syncytial virus antigenic compositions and methods
AU2011303430B2 (en) 2010-09-14 2014-09-11 Council Of Scientific And Industrial Research A synthetic immunogen useful for generating long lasting immunity and protection against pathogens
US9433671B2 (en) * 2012-03-30 2016-09-06 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
CA2913832C (en) * 2013-06-03 2023-07-04 Vlp Therapeutics, Llc A virus-like particle comprising a malaria antigen and use thereof as a malaria vaccine
CA2934472A1 (en) * 2014-01-09 2015-07-16 Alpha-O Peptides Ag Flagellin-containing protein nanoparticles as a vaccine platform
US9968665B2 (en) 2015-09-16 2018-05-15 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods

Also Published As

Publication number Publication date
AU2016322544A1 (en) 2018-03-29
CA2998540A1 (en) 2017-03-23
IL257895A (en) 2018-05-31
US20170128558A1 (en) 2017-05-11
US10588954B2 (en) 2020-03-17
CA2998540C (en) 2024-04-02
IL257895B1 (en) 2023-11-01
US9968665B2 (en) 2018-05-15
US20180221465A1 (en) 2018-08-09
JP2018529684A (ja) 2018-10-11
CN108025052B (zh) 2022-05-10
MX2018003103A (es) 2018-06-11
CN108025052A (zh) 2018-05-11
WO2017048689A1 (en) 2017-03-23
EP3349788A4 (en) 2019-06-05
IL257895B2 (en) 2024-03-01
EP3349788A1 (en) 2018-07-25
JP6934862B2 (ja) 2021-09-15
AU2016322544B2 (en) 2022-08-25

Similar Documents

Publication Publication Date Title
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
HK1256225A1 (zh) 寡核苷酸組合物及其方法
HK1255370A1 (zh) 寡核苷酸組合物及其方法
GB2546350B (en) Compositions and methods
GB2535253B (en) Compositions and methods
GB201718876D0 (en) Antithrombin-heparin compositions and methods
GB201807325D0 (en) Compositions and methods
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
ZA201707896B (en) Compositions and methods for reducing visual loss
HK1254028A1 (zh) 抗瘧疾組合物和方法
GB201502002D0 (en) Uses and compositions
GB201520255D0 (en) Composition and method
GB2550632B (en) Compositions and uses and methods relating thereto
HK1251252A1 (zh) 多核苷酸組裝的組合物和方法
GB201501991D0 (en) Uses and compositions
GB201502026D0 (en) Uses and compositions
ZA202004533B (en) Skin-brightening compositions and methods
GB201705626D0 (en) Compositions and methods
ZA201807665B (en) Methods and compositions
GB201502983D0 (en) Composition and process
GB201715820D0 (en) Compositions and methods
GB201512996D0 (en) Compositions and methods
GB201509420D0 (en) Composition and method
GB201514413D0 (en) Compositions and methods
GB201522814D0 (en) Compositions and uses thereof